The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China

Conclusions-This study demonstrates that camrelizumab treatment in patients with advanced cancers and HIV/AIDS was feasible and the clinical outcomes were acceptable.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research